Friday, 1st September 5th International Symposium on Phaeochromocytoma and Paraganglioma 2017

The conference acknowledges the support of

• From integrative OMICS studies to precision medicine in PPGLs - Anne-Paule Gimenez-Roqueplo
• New genetic loci for malignant PPGLs - Mercedes Robledo
• Pheo-type: molecular subclassification of pheochromocytoma - Richard Tothill
• Structural rearrangements involving the TERT promoter region identified in metastatic pheochromocytomas - Trish Dwight
• Targeted exome sequencing of Krebs cycle genes reveals candidate cancer predisposing mutations in pheochromocytomas and paragangliomas - Alberto Cascon Soriano

• Clinical Trials for Patients with Malignant Pheochromocytomas and Paragangliomas: What Have We Learned? Where Are We Going? - Camilo Jimenez
• Immunotherapies: a turning point for cancer treatment - Paul Neeson
• AZEDRA^® (iobenguane I 131) in patients with malignant and/or recurrent pheochromocytoma/paraganglioma (PPGL):  final results of a multi-center, open-label, pivotal phase 2b study - Daniel A. Pryma
• Evidence for Efficacy and Safety of Metirosine in Pheochromocytoma/paraganglioma: a Multi-center Trial in Japan - MITSUHIDE NARUSE

The conference acknowledges the support of

• Expression profiles of microRNA 183 family in pheochromocytomas - Alfred Lam
• Catecholamine-secreting neuroendocrine tumors: Association between catecholamine and metanephrine levels and 24-hour ambulatory blood pressure monitoring before and after tumor resection. - Debbie L Cohen
• Paraganglioma As an Independent Risk Factor for Bone Metastasis   - Mitsuhide Naruse
• Quantification of glucose metabolic rate and ¹⁸F-FDG kinetics in pheochromocytoma and paraganglioma by using dynamic PET/CT scanning   - Anouk van Berkel
• Utility of an in vitro assay of SDH activity to assess functional consequences of germline SDHB variants - Edward Kim
• Sporadic malignant paraganglioma with mixed biomarker expression at presentatation. Influence on management. - Gill Vivian
• tsAM5NE cells: a novel mouse cell model for pheochromocytomas and paragangliomas? - Peter MT Deen
• Expanding the phenotype of the fumarate hydratase germline mutation familial cancer syndrome  - Veronica Boyle
• Pheochromocytoma in Pregnancy: Case Series from a Tertiary Center from Thailand - Parichat Yimnoi
• Anti-tumorigenic and anti-metastatic activity of Aeroplysinin-1, a sponge-derived marine drug on mouse pheochromocytoma cells - Nicole Bechmann
• Deciphering genetic aberrations through metabolic profiling: 2-Hydroxyglutarate elevations in phaeochromocytoma/paraganglioma - Susan Richter
• Manipulation of the MYC/MAX complex influences pheochromocytoma cells pro-metastatic behavior - Nicole Bechmann
• Genotype and Clinical Features in Pheochromocytoma/Paraganglioma - Valeria C de Miguel
• Novel germline MAX mutations impair nuclear localisation - Edward Kim
• Combined T-SNE and ARACHNE analyses identify root molecular networks underlying subgroups of Pheochromocytoma and Paraganglioma. - Kristoffer von Stedingk
• A rare case of cardiac paraganglioma with reoperation and long-time follow-up - Xiao Ping Xing
• A giant malignant paraganglioma mimicking hepatic cancer – a case report - Shi Chen
• Variable presentation in patients with tmem127 mutations - Diana (Dindy) Benn
• A case of bilateral ACTH-secreting pheochromocytomas - Anli Tong

• A storybook to help young children understand being at risk of hereditary phaeochromocytoma and paraganglioma syndrome.       - Georgina M Schlub

• Use of somatostatin analog therapy in patients with advanced pheochromocytoma/paraganglioma and somatostatin-receptor avid disease - Debbie Cohen
• Effective preoperative embolization of the feeding arteries just before carotid body tumor resection - Kiyoto Shiga
• Cardiac paraganglioma in siblings with SDHB mutation: Evidence for a genetic or environmental modifier? - Amanda J Love
• A case of malignant paraganglioma of urinary bladder with metastatic lesions in the bone, lung, pleura, lymph node, and esophagus - Tatsuki Ogasawara
• Case: Metastatic paraganglioma with SDH C mutation - Luke Conway
• A malignant paraganglioma with intestinal fistula, anemia and SHDB gene mutation – a case report - Qi Sun

The conference acknowledges the support of: